FDA Approved: HEMLIBRA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved Hemlibra (emicizumab) from Genentech in an original application for the treatment of hemophilia A in patients with Factor VIII inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Factor Viii Inhibitors

Drugs mentioned

• Hemlibra (emicizumab)

Snippet

ORIG AP for HEMLIBRA (EMICIZUMAB)